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Abstract OTX2, a homeodomain protein essential in mouse for
the development of structures anterior to rhombomere 3, binds
with high affinity to a DNA element (called OTS) present in the
human tenascin-C promoter. Here we investigate the binding
properties of the full length recombinant human OTX2 and of
several deletion mutants to the OTS element. We demonstrate
that, upon binding of the protein to its DNA target site, a second
molecule of OTX2 is recruited to the complex and that a nearby
second binding site is not necessary for this interaction. OTX2
sequences located within a region carboxyl-terminal to the
homeodomain are necessary in addition to the homeodomain for
binding to DNA. Furthermore, OTX2 dimerization requires the
same protein domains necessary for DNA binding.
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1. Introduction
Homeodomain (HD) proteins are transcription factors that
regulate many developmental programs in eukaryotes [1,2].
Human OTX2 is a HD protein encoded by a gene related
to orthodenticle, a Drosophila gene implicated in the control
of head development [3]. In mouse, Otx2 transcripts [4] and
OTX2 protein [5] have been found in the entire embryonic
ectoderm and in the primary endoderm at the pre-streak
stage. Later during development, Otx2 becomes expressed in
the anterior portions of the embryo, mainly in the neuroecto-
derm of the headfold, fated to give rise to fore- and mid-brain
[4,5]. Three studies in homozygous null mutant mice clearly
demonstrated that Otx2 plays an essential role in the path-
ways of primitive streak formation, axial mesendoderm for-
mation and anterior head development [6^8].
The OTX2 HD is very similar to that of the Drosophila
transcription factor bicoid, characterized by a Lys residue at
position 50, corresponding to position nine of the recognition
helix [9]. Several studies indicate that Lys-50 confers the DNA
binding speci¢city to bicoid [9^12]. Thus, on the basis of the
primary structure of its HD, OTX2 has been hypothesized to
share a DNA binding speci¢city with bicoid [4,9]. Indeed, we
previously demonstrated that OTX2 is able to bind with high
a⁄nity to a target sequence (OTX2-target sequence, OTS)
present in the promoter of the gene encoding the human ex-
tracellular matrix protein tenascin-C (TN-C) [13], containing a
core element (5P-CCTAATCCT-3P) closely resembling the
binding site for bicoid present in the hunchback promoter
(5P-TCTAATCCC-3P) [10,14]. Moreover, OTX2 has been
shown to repress the transcriptional activity of the TN-C
gene promoter through the OTS sequence in transiently trans-
fected cells [13]. Recently, the role of OTX2 in regulating the
expression of a variety of cell and substratum adhesion mol-
ecules, including TN-C, has been underscored [15]. Also the
promoter of the interphotoreceptor retinoid binding protein
gene contains a sequence very similar to OTS which is bound
by OTX2 with a high a⁄nity [16].
Some HD proteins belonging to the paired class (i.e. paired)
bind cooperatively as homo- or hetero-dimers to a palindrom-
ic DNA site [17,18]. Recently, it has been demonstrated that
bicoid binds a target sequence as a monomer and that bicoid-
bicoid interactions occur when one molecule is bound to
DNA [19]. The similarity between paired, bicoid and OTX2
HDs, allowed us to hypothesize that OTX2 is able to bind to
its DNA target sequence as a dimer.
In the present study we investigated in details the binding
properties of the full length human recombinant OTX2 and of
several OTX2 deletion mutants to the OTS element found in
the TN-C gene promoter. Our ¢ndings indicate that: (i)
OTX2 is able to dimerize on the OTS sequence. (ii) OTX2
dimerization does not require the binding of the second mol-
ecule to DNA. (iii) OTX2 sequences located within a region
carboxyl-terminal to the HD are necessary in addition to the
HD for binding to DNA. (iv) The same protein domains
required for DNA binding are required for dimerization.
2. Materials and methods
2.1. Expression and puri¢cation of the human OTX2 recombinant
protein and its deletion mutants
The human OTX2 protein was produced in the Baculovirus system
according to the method previously described [13,20]. Several deletion
mutants of OTX2 (a schematic representation of OTX2 mutants is in
Fig. 4A) were produced in the Baculovirus system using the following
procedures. v1OTX2, comprising the ¢rst 746 bp of the open reading
frame of the human OTX2 cDNA (coding for the amino acids 1^249
of the sequence reported in [4]) was generated by PCR and cloned
into the EcoRI-BglII sites of the pAcSG2 Baculovirus transfer vector
(PharMingen, San Diego, CA, USA). Recombinant Baculovirus par-
ticles (Baculogold/v1OTX2) were obtained by standard procedures
[20] and the protein was puri¢ed from nuclear lysates of infected
Sf9 cells by ion exchange chromatography using Q and S sepharose
fast £ow columns (Amersham Pharmacia Biotech, Cologno Monzese,
Italy). v3OTX2, v4OTX2 and v5OTX2, encoding the amino acids 1^
179, 1^103 and 32^289, respectively, of the human OTX2 protein [4]
were generated by PCR and cloned into the EcoRI-BglII sites of the
pAcHLT-A Baculovirus transfer vector (PharMingen, San Diego, CA,
USA) in frame with the polyhistidine tag. Recombinant Baculovirus
particles (Baculogold/v3OTX2, Baculogold/v4OTX2 and Baculogold/
v5OTX2, respectively) were obtained by standard procedures [20] and
proteins were puri¢ed from nuclear lysates of infected Sf9 cells utiliz-
ing metal a⁄nity chromatography (Talon, Clontech, Palo Alto, CA,
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USA). After elution, the fractions containing the recombinant pro-
teins were dialysed and stored as described [20]. The concentration of
the puri¢ed recombinant proteins was estimated in SDS-PAGE by
densitometric scanning of silver-stained bands corresponding to di¡er-
ent amounts of marker proteins. The sequence of PCR-generated in-
serts was checked prior to their utilization.
2.2. Cells, antibodies and immuno£uorescence
Sf9 Spodoptera frugiperda cells were cultured as previously de-
scribed [20]. The rabbit anti-OTX2 antiserum is previously described
[5]. For immuno£uorescence, cytospins were prepared and ¢xed in
50% methanol/50% acetone at 320‡C for 5 min. Cells were incubated
for 2^16 h at room temperature with the anti-OTX2 polyclonal anti-
serum (1:1000 dilution) followed by extensive washes and incubation
with rhodaminated goat anti-rabbit IgG+IgM for 1 h at room temper-
ature.
2.3. Electrophoresis mobility shift assays
The preparation of nuclear extracts and the electrophoresis mobility
shift assays were conducted substantially as reported in Briata et al.
[21]. Slices of dried gels corresponding to radioactive bands (bound
and free oligonucleotides) were cut out, incubated in Ecolite (ICN
Biomedicals, Irvine, CA, USA) and counted by liquid scintillation
spectroscopy.
2.4. DNase I footprinting
A 140 bp fragment of the human tenascin-C promoter [22] contain-
ing the sequence from 3596 to 3456 was obtained by PCR. 3P End
labelling and puri¢cation of the probe were performed as described
[23]. The DNA binding reactions and electrophoresis were performed
as described [23]. An aliquot of the end-labelled DNA fragment was
also subjected to the G+A sequencing reaction [24] and loaded on the
same gel for identi¢cation of protected sequences.
3. Results
Increasing concentrations of puri¢ed recombinant OTX2,
obtained with the Baculovirus system [5,13], were incubated
with a ¢xed limiting amount of the labelled OTS oligonucleo-
tide [13] and the resulting complex was analyzed by a mobility
shift assay. When puri¢ed recombinant OTX2 is mixed with
OTS at a low protein/oligonucleotide ratio, a single complex
(M) is detected. However, when the ratio is increased, a sec-
ond slower complex (D) is observed, which becomes more and
more predominant as the ratio is further increased until vir-
tually all the available oligonucleotide is shifted to this posi-
tion (Fig. 1A).
To verify the hypothesis that OTX2 binds to OTS as a
dimer, the puri¢ed protein was mixed with OTS at a ratio
giving only the fast moving complex together with a truncated
form of OTX2 (v3OTX2), lacking the last 109 amino acids
but still capable of binding to its target sequence (see details
under Section 2 and Fig. 4A,B). v3OTX2 was added to the
mixture at a concentration su⁄cient to reach the protein/oli-
gonucleotide ratio at which the slower complex would be pre-
dominant. As shown in Fig. 1B, a complex migrating to a
position intermediate between the D and M complexes was
observed, indicating that a complex containing one molecule
of OTS and two of OTX2 (one truncated) does indeed form
when the protein/oligonucleotide ratio is increased. In order
to determine whether OTX2 dimers occured in solution, gel
¢ltration experiments using a Superdex 200 column (Pharma-
cia), pre-calibrated with protein markers, was performed.
OTX2 is a monomer in solution, migrating at a position cor-
responding to a calculated molecular mass of approximately
40 kDa (data not shown).
In the OTS sequence the TAATCC core element, known to
be bound with a high a⁄nity by OTX2 (Kd = 0.75U1039, [13]
and Table 2), is separated by four nucleotides from a lower
a⁄nity TTATC sequence (Kd = 8.2U1039, Fig. 3A,C), thus
two OTX2 molecules could independently bind to OTS with
the observed kinetics. Indeed, a DNase I footprinting analysis
indicated that the TN-C promoter region protected by OTX2
spans bases from 3535 to 3516 containing both the
TAATCC and TTATC elements (Fig. 2). To verify the role
of the TTATC sequence in the formation of the D complex in
mobility shift assays, we repeated the experiments illustrated
in Fig. 1A using the oligonucleotide m1OTS (in which the
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Fig. 1. Recombinant OTX2 binds to OTS as a homodimer. A: Electrophoretic mobility shift assay performed by incubating a ¢xed limiting
amount of the double-stranded labelled OTS oligonucleotide (0.2 nM) with increasing concentrations (3^24 nM) of puri¢ed recombinant
OTX2, as indicated. Arrows point to the faster migrating complex (M) and the slower migrating complex (D). B: Electrophoresis mobility shift
assay performed by mixing 0.2 nM of double-stranded labelled OTS oligonucleotide with increasing concentrations of wild type recombinant
OTX2 (lanes 1, 2, 3: 6, 12, 24 nM, respectively), 25nM v3OTX2 (lane 4), 6 nM wild type OTX2 plus 25 nM v3OTX2 (lane 5). The experi-
ments shown in the ¢gure are representative of three other experiments that yielded similar results.
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sequence TTATC has been mutated to TCGTC (a sequence to
which OTX2 displays only the background a⁄nity shown by
HD proteins for any random DNA sequence Kd = 4U1037,
unpublished observation)) (Fig. 3A). As expected, the Kd for
the monomeric OTX2/DNA complex formation is the same
for OTS and m1OTS (Fig. 3B). Surprisingly, despite the ab-
sence of a second binding site, the kinetics of the binding of
the second OTX2 to the M complex containing m1OTS
(Kd = 14U1039 M) is very similar to that of the dimerization
of OTX2 on OTS (Kd = 8.5U1039 M). We also measured the
dissociation rates of dimeric OTX2/DNA complexes in mobil-
ity shift assays. As shown in Table 1, the dimeric OTX2/OTS
complexes are only slightly more stable than the OTX2/
m1OTS complexes. To further investigate the importance of
the TTATC sequence in the formation of the dimeric com-
plex, we mutated TTATC to TAATC in order to obtain an
oligonucleotide containing two high a⁄nity binding sites
(m2OTS, Fig. 3A). As shown in Fig. 3B, the association be-
tween OTX2 and either OTS or m2OTS proceeds with similar
kinetics. Also the dissociation rate between OTX2 and
m2OTS is very similar to that between OTX2 and OTS (Table
1) and does not seem to be a¡ected by the presence of a
second high a⁄nity binding site. From data presented in
Fig. 3B it appears that the binding of the second OTX2 mol-
ecule is independent of the presence of a second DNA target
site but always occurs when the M complex reaches a given
concentration. To con¢rm this hypothesis, we analyzed in
mobility shift assays the interaction between OTX2 and an
oligonucleotide containing exclusively the TTATC (m3OTS,
Fig. 3A), which would form the M complex at a higher pro-
tein/oligo ratio. As shown in Fig. 3C, the a⁄nity of OTX2 for
m3OTS is more than one order of magnitude lower
(Kd = 8.2U1039 M) in comparison to the a⁄nity of OTX2
for OTS. However, the dimer is formed, even though at
high protein/oligonucleotide ratio. The dissociation rate of
the dimeric complex OTX2/m3OTS con¢rms the above de-
scribed results (Table 1).
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Fig. 2. Saturation analysis of OTX2 binding to either OTS or mu-
tants oligonucleotides. A: Sequences of the oligonucleotides used in
the experiments. The OTX2 target element and the mutated ele-
ments are underlined. B: Electrophoretic mobility shift assay per-
formed by mixing a ¢xed limiting amount (0.2 nM) of each double-
stranded labelled oligonucleotide (ab OTS, EF m1OTS, OR
m2OTS) with the indicated increasing concentrations of recombi-
nant OTX2. C: Electrophoretic mobility shift assay performed by
mixing a ¢xed limiting amount (0.2 nM) of the double-stranded la-
belled m3OTS oligonucleotide with the indicated increasing concen-
trations of recombinant OTX2. Gels were dried, autoradiographed,
and the bands corresponding to M and D complexes and to the
free probe were separately counted. The B/T value corresponds to
the ratio between either D or M radioactivity and the total radioac-
tivity input. The ¢gure shows the average of three independent ex-
periments.
Fig. 3. DNase I footprinting analysis of OTX2 recombinant protein.
A 140 bp fragment of the human tenascin-C promoter was end-la-
belled and reacted with a di¡erent amount of recombinant OTX2
(lane 1: no OTX2, lane 2: 10 ng, lane 3: 100 ng) as described under
Section 2. The lower strand footprinting is shown. On the left the
G+A sequencing reaction is shown.
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In order to de¢ne the binding/dimerization domain(s) of
OTX2, we performed the deletion mutant analysis described
under Section 2 and schematically illustrated in Fig. 4A.
Truncated OTX2 proteins were expressed with the Baculovirus
system and used in mobility shift experiments. As shown in
Fig. 4B, nuclear extracts of Sf9 cells expressing v1OTX2 and
v3OTX2, lacking 20 and 109 amino acids, respectively, at the
C-terminus and v5OTX2, lacking 31 amino acids at the N-
terminus of the protein, form complexes with OTS while
v4OTX2 protein, lacking 185 amino acids at the C-terminus,
does not. The v4OTX2 deletion mutant is correctly expressed
and translocated to the nucleus of Sf9 cells as demonstrated
by the staining of Sf9 cells infected with Baculogold/v4 OTX2
with either the anti-OTX2 polyclonal antiserum [5] (Fig. 4C)
or the KOTX2 monoclonal [13] (not shown). We also puri¢ed
the truncated OTX2 proteins to near homogeneity and the Kd
of the formation of the monomeric complex between each
puri¢ed deleted protein and the OTS sequence is presented
in Table 2. The a⁄nity of v3OTX2 for OTS is almost 20
times lower in comparison to wild type OTX2. Thus, taking
into account that v4OTX2, lacking almost the complete C-
terminus, does not bind to OTS, one can conclude that a
region C-terminal to the HD is necessary for DNA binding.
The data presented in Table 2 also indicate that each deletion
mutant which binds to OTS is able to form dimers maintain-
ing the same kinetics displayed by wild type OTX2 (data not
shown).
4. Discussion
The major ¢nding of the present work is that the full length
recombinant human OTX2 forms a dimer when bound to a
DNA target sequence and that this dimerization depends on
the interaction of a second molecule with an already DNA
bound OTX2 molecule. Some HD proteins interact with
DNA in a dimeric form but in a di¡erent way. Recombinant
paired class HDs have been reported to bind to palindromic
DNA sequences composed of two TAAT half sites [18].
Paired HD per se contains su⁄cient information to coopera-
tively dimerize on these sites, thus distinguishing the HDs of
the paired class from those of other classes which bind as
monomers [25]. Not only does OTX2 appear to dimerize on
OTS, even if this sequence does not contain any palindromic
element, but it binds and dimerizes with similar kinetics on an
oligonucleotide containing either a second site for which
OTX2 displays a very high a⁄nity (m2OTS) or a second
site for which it displays virtually no a⁄nity (m1OTS).
From Fig. 3B,C it appears that the only parameter a¡ecting
dimerization is the requirement of a pre-constituted OTX2/
DNA complex. These ¢ndings and the fact that OTX2 is a
monomer in solution, suggest that, upon binding to its target
site, OTX2 undergoes a conformational change that creates a
site on the protein for the binding of a second molecule, which
for this interaction does not need to be bound to DNA. On
the other hand, the DNase I footprinting data do not imply
that OTX2 binds to the low a⁄nity TTATC motif. It is pos-
sible that OTX2 binding to the high a⁄nity TAATC site
prevents DNase I digestion around the low a⁄nity site by
steric hindrance. Our interpretation does not exclude that a
second DNA site could be relevant in stabilizing the complex.
It is worth noting that the dissociation experiments show a
slight (two-fold) decrease in the complex stability when the
oligonucleotide contains a second site for which OTX2 dis-
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Table 1
Dissociation rates of the dimeric OTX2/DNA complexes
Time (min) 0 10 40 60
OTS 100 92 42 14
m1OTS 100 94 27 10
m2OTS 100 96 41 15
m3OTS 100 31 5 3
Electrophoresis mobility shift assays were performed by mixing either
OTS or mOTS double-stranded labelled oligonucleotides (0.2 nM)
with 24 nM puri¢ed OTX2. After a 20 min incubation at room tem-
perature (time 0), a ten-fold excess of either unlabelled oligonucleo-
tides was added and the reaction carried out for the indicated times at
4‡C. Gels were dried, autoradiographed and the bands corresponding
to the shifted complexes and to the free probes were separately
counted. Results are presented as the percentage of B/T values meas-
ured at time 0. The table shows the average of three independent
experiments
Fig. 4. Deletion mutant analysis of OTX2. A: Schematic representa-
tion of OTX2 and OTX2 deletion mutants. Details on the construc-
tion of the mutant vectors are reported under Section 2. B: Nuclear
extracts of Sf9 cells expressing the recombinant proteins were mixed
with double-stranded labelled OTS oligonucleotides and analyzed in
mobility shift assays. C: Immuno£uorescent staining with the anti-
OTX2 antiserum of Sf9 cells infected with Baculogold/v4OTX2.
Table 2








Electrophoresis mobility shift assay is performed by mixing a ¢xed
limiting amount of the double-stranded labelled OTS oligonucleotide
(0.2 nM) with increasing concentrations of recombinant OTX2. Gels
were dried, autoradiographed and the bands corresponding to the M
complex and to the free probe were separately counted. Kd values
were calculated according to Corsetti et al. [31]
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plays virtually no a⁄nity (m1OTS). Furthermore, the rele-
vance of a second DNA site could be increased by a di¡erent
spacing between the two sites that could exist in di¡erent
promoters.
The evidence that our deletion mutant v4OTX2, which
lacks the C-terminus, is unable to bind OTS underscores the
relevance of other OTX2 domains apart from the HD in
DNA binding activity. In this respect, the observation is note-
worthy that the v3OTX2, which lacks the C-terminal 109
amino acids, although still able to bind DNA and to dimerize,
interacts with OTS with an a⁄nity that is almost 20-fold low-
er than the a⁄nity displayed by OTX2, thus pointing to a
functional relevance of this region that would be interesting
to test in vivo. Other authors have demonstrated for HOM-C
proteins that sequences C-terminal to the HD in addition to
the HDs have signi¢cant functions in establishing segment
identity in Drosophila [26]. The deletion mutant analysis of
OTX2 also indicates that the same OTX2 domains (namely
the HD and the C-terminal region) required for DNA binding
are necessary for dimerization. The large deletion in v4OTX2
could per se result in protein misfolding and consequent in-
ability to bind DNA. The evidence that v4OTX2 is correctly
expressed and translocated to the nucleus of Sf9 cells where it
is recognized by both the anti-OTX2 polyclonal antiserum
and the KOTX2 monoclonal antibody, in addition to the ¢nd-
ing that also the DNA binding a⁄nity of v3OTX2 is signi¢-
cantly reduced in comparison to OTX2, makes this possibility
unlikely.
Since nearly all HD proteins are believed to bind to short,
highly related DNA sequences, the basis for their high specif-
icity of action is not yet understood. This speci¢city in vivo is
probably mediated by transcriptional cofactors. The ¢rst ex-
ample of these protein/protein interactions was provided by
the yeast proteins MATa1 and MATK2 which interact
through a short K helix located C-terminal to the MATa2
HD [27]. Recently described examples derive from the prod-
ucts of the exd/Pbx genes which have been proposed as Hox
cofactors on the basis of both genetic and biochemical evi-
dence [28,29]. Furthermore, a new family of cofactors which
confers transcriptional synergism between LIM and one of the
Otx HD proteins (P-OTX/Ptx1) has been discovered [30]. It is
then tempting to speculate that OTX2 dimerization plays a
role in modulating the ability of the protein to interact with
yet unknown cofactors.
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